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ABSTRACT 
Extracts of Hypoxis hemerocallidea corm (African potato) are commonly used by some 
traditional health practitioners in KwaZulu-Natal Province of South Africa for an array of human 
ailments. This study was, therefore, undertaken to investigate the GIT spasmolytic, 
bronchospasmolytic, uterolytic and vasa deferentia relaxant effects of Hypoxis hemerocallidea 
corm aqueous extract. Respectively, these effects were determined on both naive and spasmogen-
evoked contractions of the guinea-pig and rat isolated ileum, trachea, uterine horns and the vas 
deferens in vitro. Healthy, young adult, male and female Dunkin-Hartley guinea-pigs (300-400g) 
and Wistar rats (250-350g) were used in this study. The isolated tissues were prepared and 
mounted in Ugo Basile organ-baths under normal physiological conditions. After an equilibration 
period of 30-45 minutes, the isolated smooth tissue segments were challenged with graded 
concentrations of Hypoxis hemerocallidea corm aqueous extract, and/or reference drugs. Changes 
in tension developed by the muscle preparations (relaxations and contractions) were recorded 
isometrically by means of Ugo Basile's force-displacement transducers and pen-writing 'Gemini' 
recorders. Relatively low to high concentrations of Hypoxis hemerocallidea corm aqueous extract 
(APE, 25-400 mg/ml) produced dose-dependent and significant (p<0.05) relaxations of the 
guinea-pig ileum, and the uterine horns taken from non-pregnant rats, as well as on spasmogen-
provoked contractions of stilboesterol-primed, oestrogen-dominated, non-pregnant rats in a 
concentration-related manner. Potassium chloride (40 mM)-induced contractions of uterine horns, 
ACh (0.1-3.2 ug/ml)-induced increases in the amplitude of contractions of the guinea-pig ileum, 
as well as noradrenaline (0.2-1.6 ug/ml)-induced increases in the amplitude of contractions of the 
male rat isolated vasa diferentia, were significantly (p<0.05-0.001) reduced or abolished by bath-
applied APE (25-400 mg/ml). Relatively low to high concentrations of the extract (25-400 
mg/ml) caused concentration-dependent increases in the relaxations of the guinea-pig isolated 
tracheal smooth muscles. Inhibitions of ACh (0.1-3.2 ug/ml)-induced contractions of the guinea-
pig isolated ileum probably suggests possession of antidiarrhoeal activity of APE. Results of this 
study show pronounced relaxant effects of Hypoxis hemerocallidea corm aqueous extract on 
guinea-pig vas deferens. The study also lends pharmacological credence to the folkloric, 
ethnomedical uses of APE as a natural antenatal remedy for threatening abortions, as an 
antidiarrhoeal remedy, and as a bronchorelaxant. The precise mechanisms of APE action on the 
smooth muscles could not be established in the present study. However, the uterolytic action of 
the corm's extract is unlikely to be mediated via ^-adrenoceptor stimulation, but probably 
mediated through a non-specific spasmolytic mechanism. 
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There is a growing global interest in the use of herbs and medicinal plants as sources of 
affordable, safe and effective medicines for the management, control or treatment of human 
diseases. Erasto et al. (2005) stated that the apparent reversal of trend from Western to 
herbal medicines is partly due to the fact that synthetic drugs have always shown adverse 
reactions and other undesirable side-effects. Natural products are believed to be safer, more 
harmonious with nature, and cheaper. 
According to the World Health Organization (WHO, 1978), phytomedicines are defined as 
herbal preparations produced by subjecting plant materials to extraction, fractionation, 
purification, concentration or other physical or biological processes. These preparations 
may be produced for immediate consumption or as basis for other herbal products. Such 
plant products may contain recipient or inert ingredients, in addition to the active 
ingredients. 
WHO (2001) also defined traditional medicine as the sum-total of knowledge or practices, 
whether explicable or inexplicable, used in diagnosing, preventing or eliminating a 
physical, mental or social disease, which may rely exclusively on past experience or 
observation handed down from generation to generation, either verbally or in writing. 
Despite the limited knowledge with regard to safety, efficacy or toxicity of traditional 
medicines, a large number of rural African natives still use them to a great extent. 
Traditional practitioners are consulted much more often by these people, than those 
practicing Western medicine. In the wake of HIV/AIDS pandemic, Homsy et al. (2004) 
argued that people living with HIV/AIDS depend on, and choose traditional healers for 
psychosocial counselling and healthcare. During the Pan African Conference held in 
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Uganda (2004), it was mentioned that if the prevention and care efforts geared towards 
tackling HIV/AIDS did not engage African traditional healers, they would effectively miss 
out 80% of the African people that depend on and chose traditional healers for psychosocial 
counselling and health care. The majority of the African people, according to World Health 
Organisation, rely on traditional medicine for their primary healthcare needs as opposed to 
Western medicines. This is so because "African traditional medicine is characterised by a 
holistic approach to the spirit-mind-body concept of health, embracing people, animals, 
plants and inanimate objects, in an inseparable whole form, from which all beings derive 
their living and healing forces" (Homsy et al., 2004). 
Herbal medicines are used as primary treatment for HIV/AIDS and for HIV-related 
problems. "African Potato" is one of the African herbals that have played a major role in 
relation to this pandemic, especially here in South Africa. The herb went as far as being 
recommended by the Ministry of Health in South Africa for use in HIV, in conjunction 
with anti-retroviral treatment (Mills et al., 2005). 
The South African healthcare community is currently using Hypoxis hemerocallidea as an 
immunostimulant for patients with HIV/AIDS. Here in South Africa, Hypoxis 
hemerocallidea is being grown commercially, with controlled harvesting and preparation. 
Hypoxis hemerocallidea is popularly known as "African Potato" in English and "inkomfe" 
in isiZulu language. Other common names used for the herb in South Africa include; magic 
muthi, yellow stars, star lilly, streetwise, afril patat, ilabatheka, sterblom, gigbol, lotsane, 
olikalatsa. 
This perennial herb is widely distributed in the grasslands of southern Africa, and 
extensively used in South African Traditional Medicine for the treatment, management 
and/or control of an array of human disorders. The tuberous rootstock (i. e., the corm) of 
the herb is the morphological part of the plant that is often used for medicinal purposes. 
Decoctions and infusions of the plant's corm are often used to treat dizziness, bladder 
disorders and insanity, usually given to weak children as a tonic, and the juice is often 
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applied to burns. 
Other traditional uses of the plant's corm include treatment of testicular tumours, prostate 
hypertrophy and urinary infections (Van Wyk et ah, 2002). According to Zibula and 
Ojewole (2000), the corm of the plant has been christianised 'African potato' by the 
African natives of South Africa because of its physical resemblance to the Irish potato. 
Hypoxis hemerocallidea is a "wonder" and miracle "cure all" herb; used for the alleviation 
of many immune-related ailments, such as wounds, colds, flu, arthritis, tumour and cancer 
(Dietzch et ah, 1998) and HIV/AIDS (Erasto et al., 2005). The bitter-tasting plant is also 
said to be used in a variety of conditions, including haemorrhage, diabetes mellitus and 
prostate problems. The plant was used widely (in form of boiled tea) during the Civil War 
in Mozambique (1976-1992) by both soldiers and civilians to quickly replace lost blood 
and also used in conjunction with other plants to combat "bad blood" in patients with 
diabetes mellitus. 
In South Africa, members of the Shangaan tribe used the plant, in combination with other 
plants, for endometriosis and pre-menstrual syndrome; and the root-stock as one of the 
ingredients of the infusion taken as an "internal parasitic" and purgative. 
Hypoxis hemerocallidea is also used as a remedy for vomiting, loss of appetite, abdominal 
pains and fevers, treatment of delirium etc (http://www.natural standard.net/;© 2008). 
The corm is dark-brown or black on the outside, and yellow within, when freshly cut 
(Van Wyk et al., 2002). Figure 1 below shows the appearance of the corm. Fresh corms are 
crushed and the extract taken orally on a daily basis for very long periods of time (Mills et 
al., 2005; Erasto et ah, 2005). The growing public interest and awareness of natural 
medicines have led the pharmaceutical industry and academic researchers to pay more 
attention to this medicinal plant. 
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Fig. 1. Picture of the Hypoxis hemerocallidea corm [Family: Hypoxidaceae] 
(Adapted from van Wyk et ah, 2002) 
Several studies have been done on this "wonder plant", in relation to its fate in the body. 
In a particular study carried out to assess the toxicity of hypoxoside taken orally by 24 
patients with lung cancer, some of the results indicated the following; patient survival for 
an average of 4 months with progression of their tumours and metastases, a small 
percentage of survival for more than 1 year. In this study, no toxic effects, in clinical 
examinations or biochemical or haematological measurements were found, that could be 
ascribed to ingestion of hypoxoside. However, minor cases of anxiety, drug intolerance, 
nausea, vomiting, diarrhoea, were noted (Albretcht et al., 1995). 
Also in another study, after oral ingestion of the hypoxoside by humans (methanol extract), 
no hypoxoside or rooperol appeared in the serum, and only rooperol was present in the 
4 
faeces. The serum and urine contained at least 3 phase II metabolite peaks. Selective 
enzyme hydrolysis showed that they represent the diglucoronide, disulfate and glucuronide; 
sulfate conjugates of all three rooperol analogues (Kruger et al, 1994). Furthermore, 
Albrecht et al, 1995, reported absence of hypoxoside or rooperi in the serum. Only phase II 
biotransformation products, sulphates and glucuronides, were present in the portal blood 
and bile. It was noted that after oral ingestion of hypoxide, metabolite concentrations can 
reach relatively high concentrations. 
These studies highlight the gaps that still need to be filled, for example, determination of the 
plant's toxicity after oral ingestion. 
Besides all the claims, no satisfactory clinical trials of efficacy exist, and there is definite 
potential for drug interactions with anti-retroviral (ARV) drugs; one area where extreme 
miracles are claimed. The therapeutic effects of "African potato" have been strongly 
ascribed to the sterols, stanols, sterolins and norlignan glycoside, hypoxoside, present in the 
corm (Drews et al, 1984; Albrecht et al, 1995; Bouic et al, 1996; Nair et al, 2007). The 
anti-HIV together with the anti-cancer and anti-inflammatory activities of this herb are 
ascribed to rooperol, the aglycone of hypoxoside, which is the 4,4-diglucoside ( Van Wyk 
et al, 2002, Dietzsch et al., 1999, Mills et al, 2005 ), the sterols and sterolins. The corm is 
also known to contain stigmastanol and other sterolins. Ojewole (2000; 2003; 2005; 2006) 
reported various pharmacological actions of the corm in different experimental animal 
paradigms, ascribed the pharmacological effects to the chemical compounds of the corm. 
The long-term use of the sterols and sterolins derived from "African potato" is not 
advisable due to its immuno-suppressive effect (Mills et al, 2005). Chemical structures of 
the three best known and established constituents of the corm, hypoxoside, rooperol and P-
sitosterol, are shown in Fig. 2. 
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HO. 








Fig. 2. Structures of hypoxoside, rooperol and P-sitosterol. The biologically-inactive 
norligan diglucoside, hypoxide, is deconjugated and converted by P-glucosidase 
enzyme to form the biologically-active aglycone, rooperol. 
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Earlier studies have indicated that traditional botanical remedies can be valuable for 
treating human diseases. Potential risks and carcinogenic activities arising from long-term 
use of such remedies have, however, not been fully investigated. "The use of some 
traditional medicines has resulted in several cases of acute toxicity, leading to increased 
morbidity and mortality", Reid et al. (2006). According to Taylor et al. (2003), of the 
plants used in their study, which were recognised by traditional healers as toxic, several 
were found to be genotoxic and potentially dangerous. Limited data in literature exists with 
regard to the safety and efficacy of plant-derived medicinal products in South Africa 
(Johnson et al., 2007). 
In an effort to establish scientific basis for the claimed traditional uses of some of the 
frequently used medicinal plants, their chemical constituents and pharmacological activities 
have been recently investigated (Drewes et al, 1984; Ojewole, 2001; 2002; 2003; 2004; 
2006). 
Extensive literature search has shown a paucity of biomedical literature on smooth muscle 
effects of "African Potato". This apparent 'gap' stimulated my interest in investigating the 
effects of "African Potato" on mammalian smooth muscles in vitro. The core aim of this 
study, therefore, was to examine the pharmacological effects (i. e., contractile or relaxant 
effects) of Hypoxis hemerocallidea corm aqueous extract solution on isolated smooth 
muscles of mammalian experimental animals (namely, rats and guinea-pigs). 
The use of traditional medicines during pregnancy still plays a crucial role in the lives of the 
people living in the rural areas where modern healthcare facilities are often lacking or none 
existent. In these societies, pregnancy is often associated with a number of taboos and 
rituals to ensure successful confinement and births of healthy children (Sewram et al., 
1998; 2000). Pregnant mothers consume an array of plant concoctions, as antenatal 
remedies. These are formulated as powders, infusions, extract, and soaps; taken to induce 
or accelerate labour, prevention of threatening abortions, and to ensure successful 
confinements or deliveries. 
7 
"African Potato", the "cure all", "Zifuzonke" in isiZulu, is commonly applied (in addition to 
other herbal remedies used) for all these proclaimed activities; most especially for the 
management of threatening or premature abortions. Part of this study was, therefore, to 
investigate the uterolytic effects of "African Potato" aqueous extract in mammalian 
experimental animal paradigms in vitro. 
To evaluate the claimed traditional use of Hypoxis hemerrocallidea in the treatment of 
asthma and other respiratory disorders, the broncholytic effect of Hypoxis hemerocallidea 
was examined using the rat isolated tracheal smooth muscle. Antispasmodic effects of the 
plant were also determined using the guinea-pig ileum smooth muscle. This study also 
involved determination of the pharmacological effects of Hypoxis hemerocallidea on the rat 
vas deferens. 
This study, therefore, involved determination of the in vitro effects of Hypoxis 
hemerrocallidea aqueous extract on the extra-vascular smooth muscles of the respiratory 
system (trachea), reproductive system (uterus and the vas deferens) and the gastro-intestinal 
system (ileum) in mammalian experimental animal paradigms in vitro. 
1.2 AIMS AND OBJECTIVES 
1.2.1 AIM 
The aim of this study was to investigate the pharmacological effects of Hypoxis 
hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm ("African Potato") aqueous 
extract (APE) on some mammalian extra-vascular smooth muscles in vitro. 
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1.2.2 OBJECTIVES 
The objectives of the study were to examine the pharmacological effects of Hypoxis 
hemerocallidea on the following extra-vascular smooth muscles in vitro. 
(a) examine the uterolytic effects of APE on spontaneously-contracting 
isolated uterine horns of non-pregnant rats; as well as on acetylcholine 
and potassium chloride-induced contractions of uterine horns isolated 
from stilboesterol-primed, oestrogen-dominated, non-pregnant rats; 
(b) examine the broncho-relaxant effects of APE on isolated guinea-pig 
tracheal muscles; 
(c) examine the relaxant effects of APE on adrenaline-induced contractions 
of the guinea-pig vas deferens. 
CHAPTER 2 
2. SMOOTH MUSCLE PHYSIOLOGY 
2.1 FUNCTIONS OF SMOOTH MUSCLE. 
The smooth muscle is responsible for the contractility of hollow organs. Smooth muscles 
around blood vessels regulate blood flow through the vital organs. In the digestive and 
urinary tract systems, rings of smooth muscles, known sphincters, regulate the movement 
of materials along the internal passage ways. When made to contract, smooth muscles 
shorten, thereby propelling the luminal contents of the organs. 







Smooth muscle contraction or relaxation alters the diameters of the 
respiratory passageways, and changes the resistance to airflow. 
Smooth muscles encircling blood vessels control the distribution of 
blood, and regulate blood pressure. 
Smooth muscles around blood vessels regulate the flow of blood to 






Extensive layers of smooth muscle in the walls of the digestive tract 
play an essential role in moving materials along the tract. Smooth 
muscle in the walls of the gallbladder contract to eject bile into the 
digestive tract. 
Smooth muscle tissue in the walls of small blood vessels alters the 
rate of filtration at the kidneys. Layers of smooth muscle in the 
walls of the ureters transport urine to the urinary bladder; the 
contraction of the smooth muscle in the wall of the urinary bladder 
forces urine out of the body. 
Layers of smooth muscle help move semen along the reproductive 
tract in males, and cause the ejection of glandular secretions from 
the accessory glands into the reproductive tract. In females, layers of 
smooth muscle help move oocytes (and sperm) along the 
reproductive tract, and contraction of the smooth muscle in the walls 
of the uterus expels the fetus at delivery. 
Table. 1. Functions of smooth muscle bundles in body systems (http://cwx.prenhall.com/; 
© 1999-2000). 
Smooth muscle cell structure differs greatly from that of skeletal muscle cells, although it 
can develop isometric force per cross-sectional area that is equal to that of the skeletal 
muscle (file://E:\SMOOTH MUSCLE.htm. The speed of smooth muscle contraction is, 
however, only a fraction of that of skeletal muscle. This slow speed of smooth muscle 
contraction, in relation to skeletal muscle, can be attributed to lack of well-developed T-
tubules in smooth muscle. As a result of this, excitation of smooth muscle cell membranes 
is not quickly transmitted to the interior of the cell. This inefficiency is counteracted by the 
inherent small size of smooth muscle cells. Their size allows the events that lead to the 
increase in cytosolic free calcium, necessary for activation of the contractile mechanism, to 
occur rapidly enough (Johnson, 2003). 
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Smooth muscles around blood vessels regulate blood flow through the vital organs. In the 
digestive and urinary systems, rings of smooth muscle, known as the sphincters, regulate 
the movement of materials along the internal passage ways. When made to contract, the 
smooth muscle cells shorten, thereby propelling the luminal contents of the organ, or the 
cell shortening varies the diameter of a tube to regulate the flow of its contents. 
2.2 SMOOTH MUSCLE STRUCTURE, INNERVATION AND STIMULATION. 
Smooth muscles lack visible cross striations/banding pattern found in cardiac and skeletal 
muscles. The cells of smooth muscles range from 5 to 10 um in diameter, and from 300 to 
200 um in length. Each cell is spindle-shaped and has a single, centrally- located nucleus 
(http://cwx.prenhall.com/; © 1999-2000). 
Smooth muscle cells are of two categories; the single-unit (visceral) smooth muscle cells 
and the multi-unit smooth muscle cells. 
•Single unit smooth muscles: The cells are arranged in dense sheets or layers. A 
single-unit smooth muscle has pace-maker regions where contractions are generated 
spontaneously and rhythmically. The fibres appear to run almost parallel, but are 
densely and irregularly packed together most often, so that the narrower portion of one 
fibre lies against the wider portion of its neighbour. The initial stimulus may be the 
activation of a motor neurone that contacts one of the muscle cells in the region. Within 
each layer, adjacent muscle cells are connected by gap junctions (the plasma 
membranes of two neighbouring fibres which act as low resistance pathways for the 
rapid spread of electrical signals through the tissue. Owing to this form of connection, 
whenever one muscle cell contracts, the electrical impulse that triggered the contraction 
travels to adjacent smooth muscle cells. The contraction travels in a wave that soon 
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involves every smooth muscle cell in the region. The fibres contract in unison, that is, 
the single-unit smooth muscle is synctical. 
In intestinal smooth muscle cells, for example, membranes of adjacent smooth muscle 
cells make intimate contact with one another, such that low resistance electrical 
pathways exist (connected by gap junctions). Excitation of one cell quickly spreads (an 
increase in the intensity of contraction is due to enhanced excitation-contraction 
coupling), and a group of cells will contract in unison. 
•Multi-unit smooth muscles: These muscle cells are innervated by sympathetic and 
parasympathetic nerve fibres, and respond independently from each other, upon nerve 
stimulation. Nerve fibres have no interconnecting bridges, and are interspersed with 
connective tissue fibres. When a nerve impulse arrives at the terminal of the 
sympathetic nerve fibres, neurotransmitters released, such as noradrenaline, will reach 
and activate the effector cells by diffusion. Active cells that are touched by the nerve 
endings will then communicate with the others, via gap junctions, to form a functional 
unit. 
Multi-unit smooth muscle cells resemble skeletal muscle fibres and cardiac muscle cells 
in such a way that, neural activity produces an action potential that is propagated over 
the sarcolemma. In these muscle cells, an increase in the intensity of stimulation is 
accompanied by an increase in force, as more and more cells become active. However, 
contractions of these muscle cells are not as strong and pronounced as those of skeletal 
and cardiac muscle cells. Multi-unit muscle cells regulate a number of organs, such as 
the diameter of the pupil (located in the iris of the eye), along portions of the male 
reproductive tract (for example, the vas deferens), the walls of large arteries, and in the 
errector pili muscles of the skin. Multi-unit smooth muscle cells do not typically occur 
in the digestive tract. 
The structural organisation of single-unit and multi-unit smooth muscle cells is shown 
in Fig.3. 
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Fig. 3. Diagram showing the structure of single-unit and multi-unit smooth muscle 
fibres (file://E:\SMOOTH MUSCLE.htm). 
Smooth muscle cells primarily receive neural innervation from the Autonomic Nervous 
System. Response to innervation of a smooth muscle is either a depolarisation or hyper-
polarisation. Thus, integration occurs at the level of a smooth muscle cell, and not just 
within the central nervous system, as with skeletal muscle (Johnson, 2003). A skeletal 
muscle, on the other hand, is under the control of the somatic nervous system. 
According to Johnson (2003), mild stimulation of an excitatory nerve leads to a small 
depolarisation, but no change in tension, whereas stronger stimulations lead to development 
of an action potential, and then a contraction. Furthermore, weak stimulation of an 
inhibitory nerve leads to a membrane hyper-polarisation, but no change in resting tension. 
Stronger stimulations of the nerve, however, lead to a larger hyper-polarisation and 
relaxation. Additionally, the contractile state of smooth muscle is controlled by hormones, 
autocrine/paracrine agents, and other local chemical signals. 
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2.3 LENGTH-TENSION RELATIONSHIPS IN SMOOTH MUSCLE CELLS. 
According to Benoit et al. (1997), tension generation and muscle shortening are a 
consequence of phosphorylation of myosin by a calmodulin-dependent kinase, which 
increases the affinity of myosin, thereby promoting cross-bridge formation. 
Dephosphorylations of myosin by phosphatases are required to return actin and myosin to 
their normal low affinity states. 
In smooth muscle cells, the thick and thin filaments are not organised into sarcomeres, but 
scattered. As a result of this arrangement, tension development and resting length in smooth 
muscles, are not directly related. A stretched smooth muscle quickly adapts to its new 
length and retains the ability to contract on demand. This ability to function over a wide 
range of length is known as "plasticity". About four times greater than skeletal muscle, 
smooth muscles can contract over a wide range of lengths. This unique ability of smooth 
muscles especially comes into play in regions such as the digestive system (for example, 
the stomach) where great changes in volume occur. 
In some smooth muscles, especially those of large blood vessels, a quick stretch is followed 
by a temporary increase in wall tension. However, this increase in tension is followed by an 
almost immediate relaxation towards the original wall tension; referred to as stress 
relaxation. Reverse stress-relaxation occurs when the muscle is allowed to shorten and 
return to its original wall tension; for example, on removal of an external tensional stress. 
This ability of smooth muscles to undergo such changes is of vital importance. For 
example, in large blood vessels, this kind of response allows accommodation of different 
blood volumes by the larger blood vessels, while maintaining transmural pressure nearly 
constant. 
Despite the lack of sarcomere organisation, smooth muscle contractions can be just as 
powerful as those of skeletal muscles. Smooth muscle cells also often undergo sustained 
tetanic contractions, as experienced by skeletal muscle. 
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2.4 SMOTH MUSCLE CONTRACTION: 
A muscle contraction occurs when a muscle fibre generates tension through the action of 
actin and myosin cross-bridge cycling. It, therefore, refers to the generation of tension by 
muscle fibres, with the help of motor neurons (Wikipedia, 2008). Voluntary muscle 
contractions are initiated in the brain and involuntary reflexes by the spinal cord. 
2.4.1 Examples of the types of smooth muscle contraction: 
The action of binding/coupling of vasoconstrictor agonists with the membrane receptors is 
known to involve action of membrane-associated guanosine, 5'-troposphate (GTP) binding 
proteins, stimulation of phosphatidyl inositol turnover, and activation of protein kinase C. 
These events lead to the opening of calcium channels on the cell membrane and 
sarcoplasmic reticulum. L-type calcium channels on the sarcolemma are activated by 
voltage as well as phosphorylation. Calcium release channels on the sarcoplasmic reticulum 
predominantly respond to elevation in inositol triphosphate (IP3). Protein kinase C can 
promote vascular smooth muscle contraction even in the absence of increased cytoslic 
calcium levels. However, both the calcium dependent and the calcium independent protein 
kinase C pathways do require G-protein activation (Benoit et al., 1997). The release of 
calcium from intracellular stores and endoplasmic reticulum is one of the key transduction 
mechanisms in the regulation of numerous cellular functions, including contractility, 
protein synthesis and turnover, hormone secretion, proliferation and activation (Yusufi et 
al, 2002). 
Calcium sensitisation is observed not only in vascular but also in other visceral smooth 
muscle tissues, including airway smooth muscles. In this case, calcium sensitivity is 
referred to as the increase in smooth muscle tension and/or phosphorylation of 20-kD 
regulatory light chain of myosin (MLC20) at a constant calcium concentration. Receptor 
dependent G-protein mediated calcium sensitisation was found to occur in canine trachea 
(Yoshie/o/., 1999). 
16 
Stimulation of smooth muscle nerves causes membrane depolarisation; just like in skeletal 
muscles. Excitation, the electrochemical event occurring at the membrane, is followed by 
the mechanical event, contraction. The excitation-contraction coupling event in smooth 
muscle is termed "electro-mechanical coupling". This is made possible by the permeation 
of calcium from the extracellular space into the intracellular water of smooth muscles. An 
increase in free intracellular calcium can result from either increased influx of calcium into 
the cell through calcium channels, or by release of calcium from internal stores (for 
example, the sarcoplasmic reticulum; SR). Once in the sarcoplasm, calcium ions interact 
with calmodulin, a calcium binding protein. Calcium-calmodulin activates myosin light 
chain kinase (MLCK), an enzyme that is capable of phosphorylating myosin light chains 
(MLC) in the presence of ATP (Johnson, 2003; Benoit et al., 1997). Myosin light chains 
are 20-kD regulatory subunits found on myosin heads. MLC phosphorylation leads to 
cross-bridge formation between the myosin heads and the actin filaments, and hence, 
smooth muscle contraction. 
The concentration of intracellular calcium depends upon the balance between the calcium 
that enters the cells, the calcium that is released from intracellular storage sites (e.g., SR), 
and removal of calcium either back into storage sites, or out of the cell. Calcium is re-
sequestered by the SR by an ATP-dependent calcium pump. Calcium is removed from the 
cell to the external environment by either an ATP-dependent calcium pump, or by the 
sodium-calcium exchanger. In skeletal and cardiac muscles, on the other hand, contraction 
is triggered by the binding of calcium ions to troponin. However, one should note that 
smooth muscles (and cardiac muscle); do not contain enough calcium to fully activate the 
contractile proteins, as is observed in striated muscle which consists of well developed 
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sarcoplasmic reticuli. Varying rates of Ca influx and efflux make it possible for there to 
be moment-to-moment net gains and losses of calcium available to initiate a contraction, in 
smooth muscle cells (Johnson, 2003). 
The mechanism for smooth muscle contraction is shown in Fig. 4 below. 
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Fig. 4. Mechanism of calcium stimulation of vascular smooth muscle contraction. 
Contraction is initiated by the increase of Ca2+ in the myoplasm 
(file://E:\SMOOTH MUSCLE.htm). 
The sequence of events leading to the contractile effect is described below. 
• Ca may enter from the extracellular fluid through channels in the 
plasmalemma. These channels open, when the muscle is electrically 
stimulated, or the plasmalemma is depolarized by excess K . 
• Due to agonist-induced receptor activation, Ca2+ may be released from 
the sarcoplasmic reticulum (SR). In this pathway, the activated receptor 
interacts with a G-protein (G) which in turn, activates phospholipase C 
(PLC). The activated PLC hydrolyzes phosphatidyl inositol 
bisphosphate; one product of the hydrolysis is inositol 1, 4, 5-
trisphosphate (IP3). IP3 binds to its receptor on the surface of SR, this 
opens Ca2+ channels, and Ca2+ from SR enters the myoplasm. 
Ca2t combines with calmodulin (CaM) and the Ca2+-CaM complex 
activates MLCK, which in turn phosphorylates the light chains. The 
phosphorylated myosin filament combines with the actin filament and 
the muscle contracts. 
According to Webb, (2003), elevation of calcium concentration within the cell is 
transient, and the contractile response is maintained by the calcium-sensitising 
mechanism brought about by Rho kinase. This mechanism is said to be activated at 
the same time as the phospholipase C is activated, and involves the activation of the 
small GTP-binding protein RhoA. The nature of the activation is said to involve the 
guanine nucleotide exchange factor (RhoGEF), and migration of RhoA to the plasma 
membrane. RhoA increases Rho kinase activity upon activation, resulting in 
inhibition of myosin phosphatase. This inhibition then promotes the contractile state, 
since the light chain of myosin cannot be dephosphorylated. The state of light chain 
phosphorylation is said to be further regulated by MLC phosphatase, which removes 
the high-energy phosphate from the light chain of myosin to promote smooth muscle 
relaxation. When phosphorylated, the myosin-binding subunit of MLC phosphatase, 
inhibits the enzymatic activity of MLC phosphatase, thus allowing the light chain of 
myosin to remain phosphorylated, and hence, promoting contraction. 
2.4.1.1 Changes in load or length. 
Smooth muscles also develop tonic and phasic contractions in response to changes in load 
or length, just as skeletal muscles do. Regardless of the stimulus, smooth muscle cells use 
cross-bridge cycling between actin and myosin to develop force, and calcium ions serve to 
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initiate muscle contraction. 
2.4.1.2 Pharmaco-mechanical coupling. 
Pharmaco-mechanical coupling occurs in smooth muscles, eliciting contraction. This 
mechanism is independent of the membrane potential change; and is based on receptor 
activation by chemicals (for example, drugs) or hormones, response to local concentrations 
of oxygen or carbon-dioxide, or physical factors such as extreme stretching or irritations. 
This results in muscle cell contraction or relaxation. Mechanical events of smooth muscle 
in hollow organs serves two major roles; force development and muscle shortening, as well 
as tonic contractions, maintain organ dimensions against the imposed load . 
2.4.1.3 Signal Transduction 
The binding of an agonist (e.g. norepinephrine or oxytocin) to the surface receptor of a 
smooth muscle induces a signal that spreads from the outside to the inside of the plasma 
membrane, and activates several effectors that ultimately initiate contraction 
(file://E:\SMOOTH MUSCLE.htm). There are three components of this system, as 
discussed below (1. Inositol 1, 4, 5-trisphosphate; 2. G-proteins and 3. Phosphoinositide-
specific phospholipase C) 
• Inositol 1,4,5-trisphosphate 
The inositol ring contains six hydroxyl residues; most of them can be phosphorylated by 
specific kinases. Inositol 1-monophosphate is the constituent of phosphatidylinositol (PI) 
one of the phospholipids in animal cell membranes. PI 4-kinase and PI (4) P 5-kinase 
sequentially phosphorylate PI to generate PI (4) P and PI (4, 5) P2, respectively. Inside the 
cell membrane resides a phosphoinositide specific phospholipase C, one of its hydrolytic 
product is inositol 1, 4, 5-trisphosphate (IP3). 
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• G-proteins 
The guanine nucleotide binding proteins (G-proteins) are heterotrimers consisting of a-, b-
and g-subunits. The a-subunits appear to be most diverse, and are believed to be 
responsible for the specificity of the interaction of different G-proteins with their effectors. 
In the basal state, the a-subunit contains bound GDP (Guanine Di Phosphate), and 
association of a- band g-subunits is highly favoured, keeping the G-protein in the inactive 
form. Stimulation of the G-protein occurs when it binds GTP (Guanine Tri-Phosphate) 
rather than GDP. Receptors interact most efficiently with the heterotrimeric form of the G-
protein, and accelerate activation by increasing the rate of dissociation of GDP, and 
enhancing the association of GTP. Activation of G-protein coupled receptor results in the 
dissociation of heterotrimeric G-proteins into a-subunits and bg-dimers. Finally, the G-
protein a-subunit has an intrinsic hydrolytic activity that slowly converts GTP to GDP, and 
returns the G-protein to its inactive form. 
• Phosphoinositide-specific phospholipase C 
This term refers to a family of enzymes, all specific for the phosphoinositide moiety of the 
phosphatidylinositol, but differing in their specificity, depending on the number of 
phosphoryl groups on the inositol ring. The b-, g- and d-isoforms of Pl-phospholipase C 
(PI-PLC) show the greatest specificity for the trisphosphorylated phospholipid (PIPD)-
There are two basic mechanisms by which agonists activate PIP2 hydrolysis. In the case of 
hormones, neurotransmitters, and certain other agonists, the signal is transduced to b-
isozymes of PI-PLC. The most common pathway for PI-PLCb-isoform activation is 
initiated by stimulation of ai-adrenergic receptor (ai-R) with norepinephrine (NE), and 
involves Gaq-proteins. The activation of PI-PLC-b isoforms, is initiated by acetylcholine 
(ACh) stimulation of M2-muscarinic receptor (M2-R), and is mediated by the b g-subunit of 
the pertussis toxin-sensitive G-protein (Gi). Concerning the other basic activating 
mechanism, for example, in the case of growth factors, activation of their receptors results 
in enhanced tyrosine kinase activity. Activation of PI-PLC-g isoforms, initiated by the 
binding of epidermal growth factor (EGF) to its receptors, and executed by the tyrosine 
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phosphorylation (YP) of PI-PLC-g. In all three examples described above, the activated PI-
PLC hydrolyzes PIP2 to form the messengers, IP3 and diacylglycerol (DAG). IP3 releases 
Ca"+ from sarcoplasmic reticulum and thereby initiates smooth muscle contraction. DAG 
activates protein kinase C. However, the exact result of this activation is not known at the 
cellular level. 
2.5 SMOOTH MUSCLE RELAXATION 
2.5.1 Vascular relaxation mechanisms: 
Factors that contract vascular smooth muscles increase blood flow, hence organ perfusion. 
The balance between vascular relaxation and contraction is maintained in the resting organ 
such that resistance to blood flow and organ perfusion are maintained relatively constant 
(Benoit etal., 1997). 
Relaxation of smooth muscles occur either as a result of removal of the contractile 
stimulus, or by direct action of a substance that stimulates inhibition of the contractile 
mechanism. According to Benoit et al. (1997), the act of relaxation requires a decrease in 
the concentration of intracellular calcium as well as an increase in myosin light chain-
phosphatase activity; which decreases the rate of myosin phosphorylation. 
2.5.1.1 Effect of decreased intracellular concentrations of calcium. 
Decreased concentrations of intracellular calcium, an activator for smooth muscle 
contraction, elicit muscle cell relaxation. This calcium deficiency may be brought about by 
any of the following mechanisms: 
• Removal of cvtosolic calcium 
This involves activity of the sarcoplasmic reticulum and the plasma membrane. Sarcoplamic 
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reticular calcium binding proteins contribute to a decreased intracellular level. Examples of 
these sarcoplasmic reticular calcium binding proteins in smooth muscles include 
calsequestrin and calreticulin (Webb, 2003). ATP hydrolysis in the sarcoplasmic reticulum 
94-
results into calcium uptake. The sarcoplasmic reticular Ca , Mg-ATPase, when 
phosphorylated, bind two calcium ions, which are then translocated to the luminal side of 
the sarcoplasmic reticulum, and released. Magnesium is necessary for the activity of this 
enzyme. The enzyme binds to the catalytic site of the ATPase to mediate the reaction. This 
enzyme can, however, be inhibited by various pharmacological agents such as 
cyclopiazonic acid and vanadate (Webb, 2003). 
The Ca, Mg-ATPases are also located in the plasma membrane, and contribute to the 
reduction of calcium concentrations in the muscle cells. Plasma membrane enzyme Ca, 
Mg-ATPase is uniquely different from the same enzyme in the sarcoplasmic reticulum. It 
was observed in a study of Benoit et al. (1997), that the sarcoplasmic reticulum calcium 
pump was sensitive to stimulation by cAMP, whereas the plasma membrane-pump was not. 
This Ca-Mg-ATPase enzyme possesses an auto-inhibitory domain that can be bound by 
calmodulin, causing stimulation of the plasma membrane calcium pump. 
• Sodium/calcium exchangers 
These are located on plasma membrane, and aid in decreasing the intracellular calcium 
concentrations. The exchanger is a low affinity antiporter, and is closely coupled to 
intracellular calcium levels; and can be inhibited by amiloride and guanidine, for example. 
Inhibition of the receptor-operated and voltage-operated calcium channels located in the 
plasma membrane can lead to smooth muscle relaxation. This is so because these channels 
are important in calcium influx and smooth muscle contraction. Calcium channel 
antagonists can also be employed to elicit the relaxant effects. These include, 
benzodiazepines and dihydropyridine; which bind to distinct receptors on the channel 
protein, and inhibit calcium entry in smooth muscle. 
Figure 5 below shows the mechanism of smooth muscle relaxation. 
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Fig. 5. Relaxation mechanism of smooth muscle. Smooth muscle relaxation occurs 
either as a result of removal of the contractile stimulus or by the direct action 
of a substance that stimulates inhibition of the contractile mechanism. 
Regardless, the process of relaxation requires a decreased intracellular 
Ca2+, concentration and increased MLC phosphatase activity. The 
sarcoplasmic reticulum and the plasma membrane contain Ca, Mg-ATPases 
that remove Ca , from the cytosol(Webb, 2003). 
2.5.1.2 Mechanism of cAMP-dependent and cGMP-dependent vasodilation (Receptor-
operated vasodilation) 
According to Benoit et al. (1997), in vitro studies indicate that phosphorylation of myosin 
kinase via a cAM-dependent pathways decreases the affinity of the myosin kinase for the 
calcium-clamodurin kinase that is responsible for the phosphorylation of myosin. The result 
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is a decreased sensitivity of the smooth muscle contractile machinery. The sarcoplasmic 
reticulum calcium pump was found to be sensitive to stimulation by cAMP, whereas the 
plasma membrane pump was not. Also, cAMP dependent-protein kinases phosphorylate 
and prevent the opening of dihydropyridine sensitive calcium channels. This action is said 
to limit the rise in calcium, in response to vasoconstrictor agonists. Benoit et al. (1997), 
therefore, suggested that collectively, this results into a decreased myosin phosphorylation 
and/or decreased intracellular calcium mediated cAMP dependent vasodilation. 
In vascular smooth muscles, the actions of cGMP are largely mediated by cGMP-dependent 
kinases. As stated by Benoit et al. (1997), reports indicate that: 
i) the cGMP dependent kinases depress the rise in cytosolic calcium that occurs in response 
to vasoconstrictor agonists such as angiogenesis II. 
ii) the action of cGMP on smooth muscle is via calcium-ATPase activity, and can be 
increased by cGMP-dependent protein kinases. In this case, the net effect of increased 
cGMP-dependent kinase is to enhance calcium pump activity. 
A combination of these two actions lowers intracellular calcium, and mediates cGMP-
dependent relaxation. 




3 MATERIALS AND METHODS 
Ethical considerations 
Experimental protocols and procedures used in this study were approved by the Animal 
Ethics Committee of the University of KwaZulu-Natal, Durban 4000, South Africa; and 
conform to the "Guide to the Care and use of Laboratory Animals in Research and 
Teaching" [published by the Ethics Committee of the University of KwaZulu-Natal, 
Durban 4000, South Africa]. 
3.1 PLANT MATERIALS 
Newly-harvested Hypoxis hemerocallidea corms were purchased from Africa herbal market 
on West Street in Durban, South Africa, between November 2007 and May 2008. A 
voucher specimen of the plant has been kept in the University's Botany Herbarium. 
3.1.1 Preparation of Hypoxis hemerocallidea extract. 
Two kilograms (2 kg) of "African Potato" corms were neatly peeled and washed with 
distilled water. These were then cut into small pieces to make it easier during the blending 
process (in a Waring commercial blender). The cut pieces were weighed again, before 
blending. The wet mass was taken and found to be 1772 g (88%). 
Hot distilled water (3 litres) at 70-80°C was added to the finely blended corm and left 
standing for 24 hours in a 5-litre conical flask with occasional shaking. The flask was kept 
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air-tightly sealed and shaken from time-to-time to enhance the dissolution process of sap 
into the distilled water. After 24 hours, the supernatant was filtered from the mixture using 
a vacuum filter. Under reduced pressure in a rotary evaporator (see Fig. 6) at a temperature 
of 55±1 °C, the supernatant, in small volumes at a time, was concentrated to dryness. The 
resultant crude extract was left in the freezer over night. The dark-brown crystals of the 
extract were then scraped from the evaporation flask. These were then lightly ground to 
give a crystalline powder of 'African Potato' aqueous extract (APE). 154 g of powder were 
obtained, giving a final yield of 15 % of the powdery extract. 
Aliquot portions of the crude extract were weighed, without further purification, and 
dissolved in distilled water (at room temperature), on each day of my experiments. 
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The figure below shows the rotary evaporator. 
Fig. 6. Picture of a Rotary Evaporator (http://www.chem.ubc.ac/courseware) 
3.2 ANIMAL MATERIAL: TISSUE PREPARATION AND METHODOLOGY. 
Animals used: 
Healthy, young adult, non-pregnant female Wistar rats (250-350g) and Dunkin-Hartley 
guinea-pigs (300-400g) were used. The animals were kept and maintained under controlled 
laboratory conditions of temperature, humidity and light. They were allowed free access to 
food (standard pellet diet) and drinking tap water ad libitum. The following procedures 
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were followed, prior to smooth muscle isolation, from the respective animals employed in 
this study. 
A) Wistar rats 
The rats were euthanized by exposing them to an overdose of halothane. The rats were 
thereafter quickly placed on a dissecting table, and their abdomen opened by mid-line 
incision. Tubular segments (3-4cm long) of the uterine horns or vas deferens were then 
isolated; as described in detail by Domer (1971). 
B) Guinea -pigs. 
The guinea-pigs were euthenased with 0.6 ml of sodium pentobarbitone (PB) injection 
given via the cardiac route. The euthanased guinea-pigs were then placed on a dissecting 
table. The abdomen was opened, and small tubular pieces/segments (3-4 cm long of the 
ileum, trachea or vasa deferentia) were quickly removed. 
3.2.1 ISOLATED UTERINE HORNS 
Evaluation of the Uterolytic Activity of APE 
Animal experiments were performed following the guidelines as described by Domer, 
(1977). 
The uterus has inherent myogenic contractile activity. Bearing this in mind, therefore, both 
naive and primed uteri were used during the procedures undertaken. Since the oestrus stage 
of the rats could not be determined, virgin rats were treated with di-ethyl stilboesterol 
(Bower et ah, 1999). A dose of 0.1 mg / kg was administered subcutaneously, 18-24 hours 
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before the animal was euthenased. Female rats treated with diethyl stilboesterol were 
oestrogen dominated. This treatment is advantageous in the sense that it abolished the 
rhythmic, myogenic contractions of an untreated rat uterus, as well as increasing the 
sensitivity of the tissue to agonist drugs. 
Tissue preparation 
Two segments from the uterine horns were removed from each rat (approximately 3-4 cm in 
length) and cleaned. Any fat and connective tissue was trimmed and the horns quickly 
removed from the rat by cutting off both ends. 
The uterine horns were suspended vertically (similar to their natural anatomical hanging 
position) in 65ml Ugo Basile organ-baths, containing De Jalon's solution, of the following 
composition (g/litre): NaCl 9.0, KC1 0.42, NaHC03 0.5, CaCl2 .2H20 0.06, and glucose 
0.5; pH 7.4. The physiological solution was maintained at a temperature of 32±l°c and 
continuously bubbled with carbogen (mixture of 95% oxygen and 5% carbon-dioxide). The 
tissues were suspended under an applied tension of lg (Domer, 1971; Perez et al., 2008) 
connected to force-displacement transducers. An equilibration period of 30-45 minutes was 
allowed, during which time the tissues were washed at regular intervals of 15 minutes 
(Bower ef al, 1999). 
The isolated muscles were challenged with step-wise, graded doses of "African Potato" 
aqueous extract (APE), or selected reference drugs. Extract/drug-induced contractile or 
relaxant responses were recorded by means of Ugo Basile pen writing recorders. Extract or 
drug concentrations were repeated (where necessary) after washing out the previous 
extract/drug concentrations 3-5 times, and the tissue allowed to rest for 5-10 minutes, or 
until when the tissues returned to baseline tones. Each experiment was repeated 5-6 times, 
using new uterine horns (Perez et al., 2008). 
Two uterine horn strips from the same animal, one used as extract-treated 'test' and the 
other used as a distilled water-treated 'control' preparation, were always setup each time. 
This was done to account for the differences in tissue sensitivity. 
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Drugs used 
The following drugs were used as references: acetylcholine chloride, potassium chloride, 
oxytocin, oxotremorine and noradrenaline. Drug concentrations were made using distilled 
water on each day of the experiments. Drug concentrations quoted in the text refer to final 
organ-bath concentrations. 
The following protocol was followed during the experimental procedures: 
3.2.1.1 Effects of APE on naive female rat uterine horns 
The uterolytic effects of graded concentrations of APE (25-400 mg/ml) were examined on 
naive female rat uterine horns in the absence, and in the presence, of some agonist drugs. 
3.2.1.2 Effects of APE on uterine horns of primed female rats. 
The uterolyic effects of APE (25-400 mg/ml) on uterine horns of stilboesterol-primed 
female rats were also investigated in the absence, and in the presence, of some agonist 
drugs. 
3.2.2 RAT ISOLATED VAS DEFERENS. 
Experimental procedure 
Healthy, young adult male rats (250-300 g) were used in this study. Both ends of each vas 
deferens were tied, and the tissues were subsequently isolated, mounted and connected to 
force displacement transducers, and suspended horizontally in Ugo Basile organ-baths 
containing K-H physiological solution of composition (g/litre) : NaCl, 6.92; KC1, 0.34; 
NaH2P04, 0.15; NaHC03 ,2.1; MgCl2 , 0.11; CaCl2 , 0.26; and Glucose, 1.00. 
Each vas deferens tissue was subjected to a 1 gram tension, and the bathing (K-H) fluid was 
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continuously bubbled with carbogen. 
3.2.2.1 Determination of the effects of APE on vas deferens smooth muscle. 
Effects of graded concentrations of APE (25-400 mg/ml) were examined on rat isolated 
vasa deferentia in the absence, and in the presence, of some agonist drugs. 
3.2.3 GUINEA-PIG ISOLATED TRACHEAL SMOOTH MUSCLE 
Determination of the broncho-dilatory effect of APE 
Healthy, male Dunkin-Hartley guinea-pigs weighing 300-350 g were used in this study. 
Tissue Preparation 
The protocol outlined by Foster (1960) and Ojewole (1977) was used for the preparation of 
the tracheal smooth muscle. Guinea-pigs used were starved over-night but allowed free 
access to water. They were then euthenased with 0.6 ml of sodium pentobarbitone (PB) 
injection; given via the cardiac route. Euthanasia was preceded with an intra-muscular 
injection of ketamine/xylazine combination. 
The chest of each animal was opened, the entire trachea removed and quickly transferred to 
a Petri-dish containing warm Krebs-Henseleit physiological solution of composition 
(g/litre): NaCl 6.92, KC1 0.34, NaH2P04 0.15, NaHC03 2.1, MgCl2 0.11, CaCl2 0.26, and 
Glucose 1.00. pH adjusted to 7.4. This solution was continuously bubbled with carbogen. 
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After removal of the excess connective tissue and fat, the trachea was cut in a spiral manner, 
length-wise, through the cartilage. Each end was tied with a thread and connected to the 
transducer, under a resting tension of 1 g. The tissues were mounted, at a temperature of 37 
°C, in 65 ml Ugo Basile organ-baths containing the Krebs-Henseleit physiological solution 
which was continuously aerated with carbogen. 
The upper part of the tissue was tied with a thread and connected to a transducer, while the 
lower one was tied to a stationary wire/tube that aerated the physiological solution. 
Experimental procedure 
The tissues were allowed an equilibration period of 45 minutes, during which time the 
bathing physiological solution was changed every 15 minutes, before being challenged with 
the APE, or any other agonist drug used (Boskabady et ah, 2004; Bower et ah, 1999). 
Two muscle preparations from the same animal were used at a time; one used as the 
extract-treated 'test', and the other as distilled water-treated 'control' preparation. 
3.2.3.1 Determination of the effects of APE on tracheal smooth muscle. 
The broncholytic effects of graded concentrations of APE (25-400 mg/ml) were investigated 
on guinea-pig isolated tracheal smooth muscle preparations in the absence, and in the 
presence, of drugs such as aminophylline, nitroprusside and isoprenaline. APE 
concentrations (25-400 mg/ml) were added cumulatively to the bath fluid. 
3.2.3.2 Determination of the effects of APE on tracheal muscle, pre-contracted with 
oxotremorine. 
The relaxant effects of APE on the sub-maximal muscle tensions developed by the 
Spasmogen, oxotremorine (a muscalinic agonist) were investigated by addition of graded, 
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step-wise concentrations of APE (25-400 mg/ml). 
The APE concentrations were added to the bath solution after the peak contractile effects of 
the spasmogen had been attained. 
In each case (for each dose of APE added), when the maximal relaxation to each of the 
graded concentrations of APE had been attained, the tissue was washed-out with fresh 
physiological solution, 3 to 5 times, and then left to recover (20-30 minutes) and return to 
drug treatment base line level. Only after attaining the original base-line was the tissue 
further challenged with a subsequent dose of the spasmogen /APE. 
Changes in tension developed by the muscle preparation (contraction/relaxation) were 
recorded isometrically by means of Ugo Basile force-displacement transducers and pen-
writing 'Gemini' recorders (model 7070). 
3.2.4 GASTROINTESTINAL TRACT SMOOTH MUSCLE 
Determination of GIT spasmolytic effects of APE 
Healthy, male and female Dunkin-Hartley guinea-pigs weighing 300-350 g were used in 
this study. 
The guinea-pigs were starved over-night, prior to the experiments. 
Tissue preparation: 
Tubular segments (3-4cm long) of the ileum were removed from euthanased guinea-pigs, 
according to the procedure described by Domer (1971). 
Pieces of the ileum, (3-4 cm long) were pierced through the lumen and threads were tied at 
both ends for vertical suspension in organ-baths containing K-H physiological solution at a 
temperature of 34 °C under a lg tension each. 
Experimental procedure: 
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3.2.4.1 Determination of the effects of APE on gastro-intestinal tract smooth muscle: 
The effects of APE (25-400 mg/ml) were examined on isolated ileal tissues of the guine-pig 
in the absence, and in the presence, of some agonist drugs. 
Each added APE concentration was left in contact with the tissue until a maximum 
relaxation effect was observed and thereafter washed out with physiological solution (5 to 6 
times). The next dose was then added after a resting period of 20 minutes. 
3.2.4.2 Determination of the effects of APE on ileum tissue pre-contracted with 
acetycholine (ACh). 
After attaining graded concentration-response effect to ACh alone, the tissue was left to rest 
for about 3 minutes. The lowest concentration of APE was then added to the tissue and left 
in contact for 3 minutes. Concentration-response effect to the agonist, same as performed 
previously in the same tissue, was then repeated in presence of increasing concentrations of 
APE. The period of time between each additions of APE followed by the agonist was 
3 minutes (APE was left in contact with the tissue for 3 minutes before addition of the 
respective concentrations of the agonist). The tissue was left to rest for 10-30 minutes after 
being washed, before the next concentration-response effect was determined. 
3.3 DATA ANALYSIS 
For all the tissues employed, the experimental data obtained are presented as means 
(± SEM). Data obtained from distilled water-treated 'control' tissues were used as baseline 
values. The differences between the data obtained with the plant's extract and the reference 
drug-treated, 'test' and 'control', smooth muscle preparations were subjected to two-way 
analysis of variance (ANOVA; 95% confidence interval), followed by Bonferroni post-hoc 
tests (Graph Pad Prism, version 5; 2007). In all cases, values of P< 0.05 were taken to 
imply statistical significance. 
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CHAPTER 4 
RESULTS AND DISCUSSION 
4.1 Reproductive Smooth Muscles 
4.1.1 THE UTERUS 
4.1.1.1 Effects of APE on uterine horn smooth muscles: 
APE (25-400 mg/ml)-induced decreases in the spasmogen-provoked uterine muscle tones 
were considered as inhibitory effects of APE. The inhibitory effects of "African Potato" 
aqueous extract on the sub-maximal muscle tensions developed by each of the spasmogens 
used were investigated by sequential additions of step-wise, graded concentrations of APE 
(25-400 mg/ml) to the bath-fluid. In all cases, after the maximal relaxation to each 
concentration of APE had been achieved, the uterine horn muscle was washed out 4-5 times 
with fresh de Jalon's physiological solution, and then left to recover for 10-20 minutes and 
return to pre-drug treatment baseline level, before it was contracted again, with any of the 
standard spasmogens. 
When the uterine horn smooth muscles were left in contact with APE for a relatively long 
period of time (0.5-5 minutes), a brief initial potentiation of the amplitude of muscle 
contractions was observed. The extract, however, relaxed the muscle almost immediately 
thereafter. After attaining the maximum relaxation, the extract was washed-out with 
physiological solution and left to recover. 
The complete recovery obtained from the inhibitory effect of the extract (APE) probably 
excludes the possibility of toxic effects of the extract, at the employed concentrations, on 
rat isolated uterine smooth muscles. 
The figure 7 below shows the effect of a high dose of Hypoxis hemerocallidea corm 
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Fig. 7. Relaxant effect of APE (400 mg/ml) on a non-pregnant Wistar rat isolated uterine 
horn. APE was added to the bath-fluid at the left-hand-side solid upward-pointing 
arrow. The extract was washed-out at the right-hand-side downward-pointing open 
arrow. 
The lowest concentration of APE (25 mg/ml) produced the highest percentage of contractile 
amplitude, while the highest concentration (400 mg/ml) completely inhibited the uterine 
contractions. 
APE versus ACh-induced uterine contractions 
APE potentiated the amplitude of uterine smooth muscle contractions induced by ACh on 
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addition of cumulative concentrations of ACh (0.02-0.12 ug/ml). After wash-out, the tissue 
returned to its normal spontaneous contractions, at the same amplitude as before it was 
challenged with ACh and APE. The contractile effect of ACh (0.02-0.12 ug/ml) was found 
to be concentration-dependent. The initial increase in tissue contractile amplitude induced 
by ACh was inhibited by addition of APE; when APE was left in contact with the tissue for 
a period of 3 minutes, (see Fig.8). 
-+- ACh alone 
•*• ACh + APE (400 mg/ml) 
0.05 0.10 
Concentration of ACh (p.g/ml) 
0.15 
Fig. 8. Comparative contractile effects of APE on isolated uterine horns of a non-pregnant 
rat, in the absence, and in the presence of ACh. Each point on the graph represents 
the mean (±SEM) of 6 observations. The amplitude of contraction was measured in 
centimetres, from the baseline point. 
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4.1.1.2 Effect of APE on oestrogen-dominated female rat uterine horns. 
Uterine horns obtained from rats that had been pre-treated with stilboesterol (oestrogen 
dominated) were always quiescent and devoid of spontaneous, rhythmic contractions. 
Relatively low to high concentrations of Hypoxis hemerocallidea corm aqueous extra (APE, 
25-400 mg/ml), repeatedly relaxed the basal tones developed by the smooth muscle 
preparations in a concentration-dependent manner. 
Low to high concentrations of the plant's extract inhibited acetylcholine (ACh)-and 
potassium chloride-induced contractions of the uterine horns in a concentration-dependent 
manner. 
Spasmogen-induced tensions developed by the uterine smooth muscles were antagonised 
by increasing concentrations of APE. The relaxations of the tissues caused by additions of 
increasing concentrations of APE (100, 200 and 400 mg/ml) were concentration-related 





¥ ^ . APE + KCl 
3 minutes 
ig. 9. Representative trace showing the relaxant effects of APE (50, 100, and 200 mg/ml, 
respectively) added cumulatively to the bath-fluid at the right-hand-side 1, 2 and 3 
solid down-ward-pointing arrows. The primed rat isolated uterus was depolarized 
by addition of KCl (40 mM), at the left-hand-side solid upward-pointing arrow. 






Potassium chloride + APE 
Control 
* * * 
APE Concentration (mg/ml) 
Fig. 10. Effect of increasing concentrations of APE on KCl-contracted oestrogen-
dominated uterus. APE (50, 100, 200 and 400 mg/ml) were added cumulatively to 
the bath-fluid. Values presented are means (±SEM) of 6-8 observations. (* 
(p<0.05), ** (p<0.1) and *** (p<0.001) versus the control. 
APE inhibited uterine smooth muscle contractions induced by high KCl (40 mM). APE 
(400 mg/ml) produced complete relaxation of the high KCl-induced contractions. This 
probably suggests that APE may block the influx of calcium through the L-voltage-
dependent calcium channels (Perez et al., 2008). This inhibition of calcium is said not to 
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depend on NO (nitric oxide) and/or beta-adrenergic receptors; and can be reversed by 
addition of calcium; which suggests, according to the investigators (Perez et al., 2008) that 
the drug in question/used in their study, acted on L-voltage-sensitive calcium channels. 
According to Gutierrez et al. (1998), the relaxant effect of 17a-oestradiol on rat uterus 
could be produced by reduction of calcium influx, and induction of polyamine synthesis by 
transcriptional mechanisms that do not involve oestrogenic receptors. In this same study, 
17a-oestradiol relaxed KCl-induced tonic contractions in a concentration-dependent 
fashion. The mechanism was postulated not to be mediated by oestrogenic receptors or 
cAMP. The study by Revuelta et al. (1997) also supported these findings, stating that drugs 
with oestrogenic activity produce vascular and uterine smooth muscle relaxations by 
inhibiting calcium influx through a non-genomic mechanism of action. In this study, 
therefore, the uterolytic action of the corm's extract is unlikely to be mediated via (32-adrenoceptor 
stimulation but probably mediated through a non-specific spasmolytic mechanism. 
4.1.2 THE VAS DEFERENS 
The vas deferens muscle is not spontaneously-active and normally contracts only in 
response to neural stimulation or exogenous spasmogen administration. The sympathetic 
nervous stimulation gives rise to an excitatory junction potential which add to each other, 
and when a critical value is reached, a spike is initiated. In the guinea-pig vas deferens, the 
spikes are all-or-none, with over-shots of 20mv (Chinoy et al., 1983). 
The vas deferens smooth muscle contraction is generally associated with alpha-
adrenoceptor stimulation, and relaxation with beta-adrenoceptor stimulation. Alpha-
receptor activation involves an increase in permeability to calcium, whereas activation of 
beta-receptors promote a decrease in calcium permeability and hence, relaxation. The 
calcium that activates noradrenaline-induced contractions originates from the loosely-
bound calcium pool in extra-cellular fluid, as well as from the pool of tightly-bound 
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calcium (bound to calmodulin, a polypeptide which acts as an activator for norepinephrine 
release and muscle contraction), found intra-cellularly in the muscle fibre (Chinoy et al., 
1983). In the same cited study, the density of innervations of the vas deferens, the amount 
of calcium, sodium and potassium ions found in each, were noted to complement the 
physiological properties of the right and left vas deferens. It was thought probable that, the 
left vas deferens was more innervated, containing more of the calmodulin-bound calcium 
intra-cellularly, and less sodium, and hence, more responsive to graded concentrations of 
adrenaline and noradrenaline. 
Adrenaline was used in the present study to contract the vas deferens smooth muscle, prior 
to addition of APE (Walland et al; 1997). This sympathetic agonist plays a role in the 
release of calcium in the smooth muscle. Noradrenaline released from the sympathetic 
nerves acts on a i-adrenoceptors to increase systosolic calcium, and promote the smooth 
muscle contraction. 
The vas deferens is an example of a multi-unit smooth muscle. It exhibits little or no 
spontaneous activity; and depends on nervous stimulation for activation and generation of 
force (neurogenic force). Many of its muscle cells are, however, in direct contact with 
innervating nerve fibers, and communicate with each other via gap-junctions, as described 
earlier in Chapter 1. 
An increase in the frequency of nerve impulses promotes a temporal summation of 
excitatory post synaptic potentials, and hence, generation of calcium-dependent action 
potentials and calcium influx, hence increasing neurogenic tone. Increase in impulse 
frequency of nerves enhances the rate of neurotransmitter release and membrane receptor 
occupancy by their respective agonists. 
An influx of calcium can be blocked by antagonists of noradrenaline receptors (ai-
adrenergic receptors), as well as by calcium-channel blockers (calcium antagonists), and by 
drugs that open potassium channels (potassium agonists) which cause hyper-polarisation 
and in turn, close the voltage-dependent calcium channels. 
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4.1.2.1 Determination of the effects of APE on vas deferens tissues, pre-contracted with 
adrenaline. 
Adrenaline (0.2-1.6 ug/ml) induced concentration-related contractions of the rat and guinea-
pig vasa deferential smooth muscles. Addition of APE (25-400 mg/ml) relaxed the muscles 
and antagonised adrenaline-induced contractions of the tissues. The observed effects of 
increasing concentrations of adrenaline, alone and in presence of the APE are shown in 
Figure 11. 
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lg APE APE APE 
i • . 
3 minutes 
Fig. 11. Effects of increasing concentrations of adrenaline, alone (panel A), and in the 
presence of APE (panel B), on adrenaline-induced contractions of guinea-pig 
isolated vas deferens. The solid dots 1-4 indicate points of addition of adrenaline 
(0.2, 0.4, 0.8 andl.6 ug/ml)/and APE, 1-3 (100, 200 and 400 mg/ml), respectively. 
Each of the respective concentrations were left in contact with the tissue for 30 











Noradrenaline + APE 
1 -b 
Concentration 
Fig. 12. Inhibitory effects of APE on noradrenaline-induced contractions of the vas 
deferens. Points 1 to 4 represent concentrations of noradrenaline (0.2, 0.4, 0.8, 
1.6 ug/ml) and APE (50, 100, 200 and 400 mg/ml), respectively. Each value is a 
mean (±SEM) of 6-8 observations. * (p<0.05), ** (p<0.1) and *** (p<0.001). 
Table 2 shows the data analysed to give Figure 11 above. The analysis was done using 2-
way ANOVA, followed by Bonferroni post-hoc test. 
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P < 0.05 
PO.01 
PO.001 
-0.3000 -1.638 to 1.038 
-1.500 -2.838 to-0.1617 
-2.150 -3.488 to-0.8117 






Table. 2. Data analysed to give Figure 11 (2-way ANOVA, followed by Bonferroni 
post-hoc test). Inhibitory effects of APE on adrenaline-induced contractions 
of the vas deferens. 
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The inhibitory effects of APE on adrenaline-induced contractions of the vas deferens are 
thought to be due to antagonism of a i .adrenergic receptors. 
4.2 Respiratory Smooth Muscle 
4.2.1 Effects of APE on guinea-pig isolated tracheal smooth muscles 
Agonist-receptor interactions regulate airway smooth muscle tone through activation of 
guanine nucleotide binding proteins (G-proteins), which are coupled to second messenger 
pathways that mediate changes in the tissue's contractile state. According to Hakon et al. 
(1998), with respect to airway smooth muscle contraction, receptor activation elicits 
phosphatidylinositol turnover that results in the formation of the second messengers, 1, 2-
diacylglyserol, which activates protein kinase C (PKC), and inositol 1, 4, 5-triphosphate, 
which binds to its intracellular receptor to mobilise intracellular calcium. Both the 
mobilisation of calcium and activation of PKC play critical roles in initiating and acutely 
modulating the intensity and duration of the airway smooth muscle contraction. 
Bronchodilator-agonist mediated receptor activation is typically coupled to an enhanced 
accumulation of the second messenger, adenosine 3', 5', -cyclic monophosphate (cAMP) 
which, through activation of cAMP-dependent protein kinase, induces posphorylation of 
specific proteins, leading to airway smooth muscle relaxation. 
In a study by Yoshii et al. (1999), relaxation of intact trachea was attributed to selective 
inhibition of the protein rho/ROCK (rho- associated coil-forming protein kinase) pathway 
by Y-27632. Calcium sensitisation through this pathway was thought to play a role in the 
sustained phase of airway smooth muscle contraction, including human airway smooth 
muscle. Inhibition of this rho/ROCK signalling was also thought to become the new 
strategy to resolve airflow limitations in diseases such as bronchial asthma. 
APE (25-400 mg/ml) relaxed guinea-pig isolated tracheal smooth muscles. The muscles 
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were then contracted with oxotremorine (lug/ml). Figure 12 shows typical traces obtained. 
3 minutes 
Fig. 13. Comparative relaxant effects of APE (25-400 mg/ml) on two different isolated 
tracheal tissues of the guinea-pig. The solid dots 1 to 4 indicate APE, 25, 50, 100 
and 200 mg/ml, respectively, exogenously added to the bath-fluid. The upward-
pointing solid arrows indicate the points of addition of oxotremorine (lug/ml). The 
tissues were washed-out 5 times at the downward-pointing right-hand side arrows. 
The results in this study indicate that APE, like isoprenaline, aminophylline, nitroprusside, 
inhibited and relaxed spasmogen-evoked contractions of guinea-pig isolated tracheal 
muscle preparations in a concentration dependent manner. This observation suggests that 
APE has a bronchodilatory property. The exact mechanism of the bronchospasmolytic 
action APE in this regard is not known; but is likely to be due to stimulation of the beta2-
adrenoceptors that are abundant in the bronchial smooth muscle. According to Ojewole and 
Nyinawumuntu, 2008 (unpublished observations), this hypothesis is strengthened by the 
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following observations: 
i) aminophylline and nitroprusside produced pharmacological effects that are similar to 
those of APE on guinea-pig tracheal muscle preparations, and 
ii) concentrations of propranolol which markedly inhibited or completely abolished the 
bronchospasmolytic effect of isoprenaline did not affect the bronchospasmolytic action of 
APE. 
In the same study, it was also observed that APE inhibited the spasmogenic action of 
potassium on the tracheal smooth muscle preparations. This observation probably suggests 
that the plant extract is unlikely to produce its bronchodilatory effects through a specific 
receptor, but rather, through a non-specific bronchospasmolytic mechanism. 
4.3 Gastro Intestinal Tract Smooth Muscle. 
4.3.1 Effects of APE on guinea-pig isolated ileal smooth muscles. 
The contractile pattern of the guinea-pig isolated ileum was first determined. The ileum was 
found to possess its own myogenic contractions. These myogenic contractions of the ileum 
were inhibited or abolished by APE (25-400 mg/ml). On washing out the APE, the tissue 





Fig. 14. Relaxant effects of single concentrations of APE (100 and 300 mg/ml) on 
two different pieces of guinea-pig isolated ileum. The concentrations of APE 
were sequentially added to the bath-fluid at the left-hand-side solid upward-
pointing arrows, left in contact with the tissue for 3 minutes, and then 
washed out at the right-hand-side downward-pointing arrows. 
4.3.2 Effects of APE on ACh pre-contracted ileal smooth muscles. 
Contractions of the ileal muscles provoked by the ACh were inhibited or abolished in a 
concentration-related manner by APE (25-400 mg/ml). Figure 14 shows a typical trace 
096861 
obtained in response to graded concentrations of ACh (0.1-3.2 ug/ml) in the absence (panel 
A), and in the presence, of APE (200 mg/ml), (panel B). 
Fig. 15. Effect APE (200 mg/ml) on ACh-induced contractions of guinea-pig isolated 
ileum. Contractions of the tissue were induced by sequential additions of increasing 
concentrations of ACh (0.1-3.2 ug/ml, respectively) to the bath-fluid at the clear 
dots 1-6 (panel A). The solid dots 1-6 (panel B) indicate additions of both APE (200 
mg/ml) and ACh (0.1-3.2 ug/ml, respectively) as in panel A. 
APE (25-400 mg/ml) antagonised ACh- and other spasmogen-inducedcontractions of the 
guinea-pig ileum in a concentration-related manner. The spasmolytic effect of APE is 
thought to be mediated via a non-specific mechanism. 
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Source of Variation % of total variation 
Interaction 
Concentration of ACh 
% Contraction 
Source of Variation P value 
Interaction 
Concentration of ACh 
% Contraction 
Source of Variation Df 
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% Contraction Conc.of ACh (0.1-3.2 ug/ml) ACh + Extract Difference 
diff. 
Row 1 2.00 
Row 2 2.85 
Row 3 3.88 
Row 4 5.43 
% Contraction Difference 
Rowl -1.53 
Row 2 -2.58 
Row 3 -3.48 

























95% CI of 




Table. 3. Results of two-way ANOVA analysis of data. Concentration of ACh (0.1-
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ACh + APE(200rrg/ml) 
ACh alone 
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Concentration 
ACh (pg/ml) 
Fig. 16. Relaxant effect of APE on ACh-induced contractions of guinea-pig isolated ileum. 
The responses shown represent; A (ACh alone), B (ACh + APE) and C (ACh alone 
after wash-out). Each value is the mean (±SEM) of 6 observations. (* (p<0.05), 
** (p<0.1) and *** (p<0.001) versus the control. Concentrations 1 to 4 are 
represented in Table 3 (Rows 1-4). 
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CHAPTER 5 
5 CONCLUSION AND RECOMMENDATIONS. 
The results obtained in the present study support some of the folkloric claims about the 
therapeutic effects of "African potato". Experimental evidence obtained in the present 
laboratory animal study indicates that Hypoxis hemerocallidea corm aqueous extract (APE) 
possesses uterolytic, vas deferens and guinea-pig ileum smooth muscle relaxant, and 
bronchodilatory activities. These findings lend pharmacological support to the anecdotal, 
ethnomedical uses of 'African Potato' in some rural communities of South Africa. 
Generally, the exact mechanisms of action of the plant's extract on the smooth muscles 
studied were, however, not established. I would, therefore, recommend further investigations 
in this regard. Such an investigation should include determination of the effects observed in 
this study, in presence of other known agonists and antagonists under various experimental 
conditions both in vivo and in vitro. 
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Abstract 
Extracts of Hypoxis hemerocallidea corm (African potato) are commonly used by some 
traditional health practitioners in KwaZulu-Natal Province of South Africa as natural 
antenatal remedy to prevent threatening or premature abortion and miscarriage, and to 
ensure successful confinement. In this study, we investigated the uterolytic activity of H. 
hemerocallidea corm aqueous extract on spontaneous, rhythmic contractions of uterine 
horns taken from pregnant rats and guinea-pigs, as well as on spasmogen-provoked 
contractions of stilboesterol-primed, oestrogen-dominated, non-pregnant rat and guinea-
pig isolated uterine horns. Relatively low to high concentrations of H. hemerocallidea 
corm aqueous extract (APE, 25-400 mg/ml) inhibited the amplitude of the spontaneous, 
rhythmic contractions of, and relaxed, uterine horns isolated from pregnant rats and 
guinea-pigs in a concentration-related manner. Furthermore, relatively low to high 
concentrations of APE (25-400 mg/ml) relaxed basal tones of uterine horns taken from 
non-pregnant, oestrogen-dominated rats and guinea-pigs in a concentration-dependent 
manner. The same moderately low to high concentrations of APE (25-400 mg/ml) 
inhibited acetylcholine-, oxytocin-, bradykinin-, and potassium chloride (K*)-induced 
contractions of oestrogen-dominated rat and guinea-pig isolated uterine horns in a 
concentration-related manner. Although the mechanism of uterolytic action of APE could 
not be established, the results of the present study lend pharmacological credence to the 
folkloric, ethnomedical uses of APE as a natural antenatal remedy for threatening or 
premature abortion, and suggest that the uterolytic action of the corm's extract is 
unlikely to be mediated via /^-adrenoceptor stimulation, but probably mediated through a 
non-specific spasmolytic mechanism. 
Keywords: Hypoxis hemerocallidea corm, African Potato, aqueous extract (APE), 
natural antenatal remedy, threatening or premature abortion 
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Introduction 
Despite the remarkable advancement made in orthodox medicine within the last few 
decades, available biomedical evidence indicates that in South Africa, approximately 80% of the 
black Africans still rely on traditional health practitioners and medicinal plants for their daily 
healthcare needs. The use of traditional medicines during pregnancy still plays a crucial role in 
the lives of the people living in rural areas where modern healthcare facilities are often lacking. 
In many rural African communities, pregnancy is usually accompanied by many traditional 
taboos and ceremonies to ensure successful confinement and births of healthy children (Sewram 
et al. 1998; 2000). In the rural communities, various morphological parts of an array of plants 
from diverse families and species are usually consumed by pregnant women as antenatal 
remedies. Such antenatal remedies are traditionally formulated as powders, extracts, infusions, 
decoctions, concoctions, bath soaps, and so forth, to ensure successful confinement, and/or to 
induce or accelerate labour at full-term. Many known medicinal plants are used as natural 
remedies to induce or accelerate labour (Sewram et al. 1998; 2000), while a few others are used 
to prevent threatening or premature abortion, and ensure successful confinement. 
Unfortunately, however, the quality, safety and efficacy of most herbal medicines and plant 
products used as South African traditional antenatal remedies have not been subjected to 
scientific scrutiny. One of such frequently-used South African antenatal medicinal plants is 
Hypoxis hemerocallidea (Fisch. & C.A. Mey.; family, Hypoxidaceae). This 'cure-all' medicinal 
plant of South Africa is a tuberous, perennial herb with long, strap-shaped leaves and yellow, 
star-shaped flowers. The broad and slightly hairy leaves of H. hemerocallidea are arranged one 
above the other to form three distinct groups of leaves spreading outwards from the centre of 
the plant, while the bright yellow, star-shaped flowers are borne on long, slender stalks (Van 
Wyk et al., 2002). The tuberous rootstock (i.e., the 'corm") of the herb is popularly known as 
'African Potato' in South Africa, and is widely used in South African traditional medicines as a 
remedy for a catalogue of human ailments. The traditional healers of South Africa have 
employed the corm of the plant as a "muthi" (isiZulu word for "medicine") for centuries, and now, 
the humble African Potato has been claimed to be a 'miracle plant medicine' in the fight against 
various modern and 21st century diseases of mankind. This South African 'cure-all miracle plant 
medicine' has been claimed to be an effective remedy against HIV/AIDS-related diseases, 
arthritis, yuppie flu, hypertension, diabetes mellitus, cancer, psoriasis, gastric and duodenal 
ulcers, tuberculosis, urinary tract infections, asthma, and some central nervous system (CNS) 
disorders, especially epilepsy and childhood convulsions (Watt and Breyer-Brandwijk, 1962; 
Hutchings, 1989; Pujol, 1990; Hutchings et al. 1996; Albrecht, 1995; Albrecht et al, 1995; Van 
Wyk et al, 2002). The above pharmacotherapeutic effects of African Potato have been strongly 
ascribed to the sterols, stands, sterolins and norlignan glycoside, hypoxoside, present in the 
corm (Drewes et al, 1984; Albrecht et al, 1995; Bouic et al, 1996; Nair et al, 2007). The best-
known and fully-established chemical constituents of the plant's corm are presented in Fig. 1. 
The effects of some cations, anions and certain drugs on spontaneous activities of uterine 
smooth muscle strips taken from non-pregnant and pregnant mammals have been investigated 
and reported by a number of workers (Kuriyama and Suzuki, 1976; Osa and Kawarabayashi, 
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Fig. 1. Structures of hypoxoside, rooperol and /^sitosterol. The biologically-inactive 
norlignan diglucoside, hypoxoside, is deconjugated and converted by /J-ghicosidase 
enzyme to form the biologically-active aglycone, rooperol. 
1977; Kuriyama et al., 1998). According to Kuriyama et al. (1998), visceral smooth muscle cells 
play a critical role, through changes in their contraction-relaxation cycle, in the maintenance of 
homeostasis in biological systems. The investigators further observed that features of the cells 
differed markedly from one tissue to the other, and from one species to another. The workers 
also noted that often, there were regional differences within a given tissue. 
Using micro-electrode techniques, Kuriyama and Suzuki (1976) investigated the changes in 
membrane electrical properties of rat myometrium during gestation and following ovarian 
hormone treatments. The investigators recorded spontaneously-generated bursts of electrical 
activity, alternating with silent periods, from non-pregnant, pregnant and postpartum myometria, 
and found that membrane potential was highest during the middle stage of gestation, although 
the spike amplitude within a burst was not uniform. The investigators further observed that in 
the final stage of gestation and during parturition, the membrane potential was low, and that the 
spikes within a burst were of low frequency and uniform amplitude. Kuriyama and Suzuki (1976) 
further observed that the resting and active membrane properties of progesterone-treated 
myometria were similar to those seen during the middle stages of gestation. 
Osa and Kawarabayashi (1977), using the double sucrose gap method, investigated the 
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effects of Na*, Ca2*, anions and isoprenaline on the plateau potential in circular muscles of 
pregnant rat myometrium, and observed that the amplitude and duration of the plateau potential 
increased by raising the concentration of the external Ca2* to between 0.3 and 3 mM, and that 
the plateau potential decreased when the external Ca2* concentration was further increased. 
The investigators also observed that the plateau potential was prolonged in low Na+ solution, and 
that isoprenaline increased membrane conductance and depressed the plateau. 
However, the present study was prompted by the claim of some traditional health 
practitioners in KwaZulu-Natal Province of South Africa that decoctions, infusions and extracts 
of Hypoxis hemerocallidea corm are effective antenatal remedies for the treatment, management 
and/or control of threatening or premature abortions. The aim of this study was, therefore, to 
investigate the uterolytic action of African Potato aqueous extract in mammalian experimental 
animal paradigms in vitro. 
Matetrials and methods 
Ethical considerations 
The experimental protocols and procedures used in this study were approved by the Animal 
Ethics Committee of the University of KwaZulu-Natal, Durban 4000, South Africa; and conform 
to the "Guide to the Care and Use of Animals in Research and Teaching" [published by the Ethics 
Committee of the University of KwaZulu-Natal, Durban 4000, South Africa]. 
Animals 
Healthy, young adult, pregnant and non-pregnant (normal) female Wistar rats (250-350 g) 
and Dunkin-Hartley guinea-pigs (300-400 g) were used. The animals were kept and maintained 
under laboratory conditions of temperature, humidity, and light; and were allowed free access to 
food (standard pellet diet) and drinking tap water ad libitum. Some of the non-pregnant 
(normal) rats and guinea-pigs were pre-treated with stilboesterol (0.2 mg/kg s.c.) 20-24 hours 
before use. Vaginal smears were taken immediately before sacrifice in order to ascertain that 
the animals were in oestrus. Pregnancy was established in mated rats and guinea-pigs by 
examining the animals daily for the presence of cervical plugs. The day on which cervical plug 
was first found was taken as 'day one' of pregnancy. Early pregnancy was regarded as days 1-
8, middle gestation period was taken as days 10-14, and late pregnancy was taken to be days 16-
20. All the animals were fasted for 16 hours, but still allowed free access to drinking tap water, 
before the commencement of our experiments. 
Plant material 
Fresh corms of Hypoxis hemerocallidea (African Potato) were purchased from a fruit kiosk 
along West Street in Durban, KwaZulu-Natal Province of South Africa, between June and 
November, 2007. The corms were identified and authenticated by the staff of Botany 
Department, University of KwaZulu-Natal (where a voucher specimen of the plant has been 
deposited). One kg of the fresh corms were washed with distilled water, cleaned, cut into 
smaller pieces and milled in a waring commercial blender. The milled corm was macerated in 
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distilled water and extracted twice, on each occasion with 2.5 1 of distilled water at room 
temperature (26 ± 1°C) with occasional shaking for 48 hours. The combined distilled water 
solubles obtained were concentrated to dryness under reduced pressure in a rotary evaporator at 
60 ± 1°C. Freeze-drying and solvent elimination of the crude aqueous extract gave 78 g (i.e., 7.8% 
yield) of a dark-brown, powdery, 'African Potato' aqueous extract (APE). Without any further 
purification, aliquot portions of the crude extract residue (APE) thus obtained were weighed and 
dissolved in distilled water (at room temperature) for use on each day of our experiments. 
Acute toxicity testing 
The median lethal dose (LD50) of APE was determined in mice by a modified method of 
Lorke (1983), using intraperitoneal and oral (intragastric) routes. Mice fasted for 16 hours were 
randomly divided into groups of 10 mice per group. The procedure described in detail earlier by 
Ojewole (2006) was used for the determination of the acute toxicity of the plant's extract in the 
mice, following intrapritoneal and oral routes. 
Evaluation of uterolytic activity of APE 
Each non-pregnant (normal) or pregnant animal was euthanized with halothane inhalation 
and bled out. Its two uterine horns were carefully cleaned free from extraneous and connective 
tissues, trimmed and quickly removed. Tubular segments of approximately equal lengths (2-3 
cm long) were removed from the uterine horns by cutting off both ends. The two uterine horn 
segments thus obtained were separately suspended in 30-ml Ugo Basile's two-chambered organ-
baths (model 4050) containing de Jalon's physiological solution (DJS, of composition, in g/1: 
NaCl, 9.0; KC1, 0.42; NaHC03, 0.5; CaCl2.2H20, 0.06; and glucose, 0.5) maintained at 32 ± PC 
and continuously aerated with carbogen (i.e., 95% 0 2 + 5% C02 gas mixture). Each uterine horn 
strip was subjected to an applied resting tension of 1 g, and allowed to equilibrate for 45-60 min, 
during which time the bathing de Jalon's physiological solution (DJS) was changed every 15 min 
before it was challenged with stepwise, escalated concentrations of APE (25-400 mg/ml) alone, 
or sequential doses of acetylcholine (ACh), oxytocin, bradykinin or potassium chloride. Two 
uterine horn strips from the same animal, one used as extract- or drug-treated 'test', and the 
other one used as distilled water-treated 'control' preparation, were always set up at a time (in 
order to make allowance for changes in tissue sensitivity). The 'control' uterine horn strips 
were always treated with distilled water (0.1-0.5 ml) only. Sub-maximal contractions (i.e., 70-
80% of the maximum contractions) of the drug-treated 'test' preparations were elicited by 
sequential, exogenous additions of either ACh (1 /jg/tnl), oxytocin (0.5 JJU), bradykinin (5 ng/ml), 
or potassium (K\ 30 mM) to the bath fluid. Sub-maximal muscle tensions developed by the 
spasmogens used were similar, and approximately equal to 1.5 g. APE-induced decreases in the 
spasmogen-provoked muscle tensions were considered as inhibitory effects of APE. The 
inhibitory effects of APE on the sub-maximal muscle tensions developed by each of the 
spasmogens used were investigated by sequential additions of stepwise, graded concentrations 
of APE (25-400 mg/ml) to the bath-fluid, followed, 2-3 min later, by subsequent additions of any 
of the spasmogens used to the bath fluid. 
In all cases, after the maximal relaxation to each of the graded concentrations of APE had 
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been achieved, the uterine horn muscle preparation was washed out 3-5 times with fresh de 
Jalon's physiological solution, and then left to recover (for 10-20 min) and return to pre-drug 
treatment baseline level before it was contracted again with any of the standard spasmogens. 
Changes in tension developed by the uterine horn preparations (contractions and/or 
relaxations) were recorded isometrically by means of Ugo Basile's force-displacement 
transducers and pen-writing 'Gemini' recorders (model 7070). 
Drugs 
The following reference drugs were used: acetylcholine chloride, potassium chloride (Sigma 
Chemical Co.), oxytocin (Parke-Davis), and bradykinin (Sandoz). All drugs were dissolved and/ 
or diluted in distilled water on each day of our experiments. Drug concentrations quoted in the 
text refer to final organ-bath concentrations. 
Data analysis 
Experimental data obtained are presented as means (± SEM). Data obtained from distilled 
water-treated 'control' uterine horn muscle strips were used as baseline values. The differences 
between the data obtained with the plant's extract- and reference drug-treated 'test' uterine horn 
muscle preparations, and the data obtained with distilled water-treated 'control' uterine horn 
muscle strips, were subjected to one-way analysis of variance (ANOVA; 95% confidence interval, 
GraphPad Prism 5), followed by Dunnett's post-hoc test (Dunnett and Goldsmith, 1993). In all 
cases, values of P<0.05 were taken to imply statistical significance. 
Results 
Acute toxicity study 
The LD50 value for intraperitoneally-administered APE was found to be 1,785 ± 116 mg/kg, 
while the LD50 value for orally-administered APE was 3.72 ± 0.45 g/kg. Oral administration of 
APE up to 2.5 g/kg did not produce any visible toxic manifestations (e.g., respiratory distress, 
uncoordinated muscle movements, etc) or mortalities in mice. 
Effects of APE on uterine horns isolated from pregnant rats and guinea-pigs 
Uterine horns taken from pregnant rats and guinea-pigs exhibited spontaneous, rhythmic, 
pendular contractions. Relatively low to high concentrations of APE (25-400 mg/ml) inhibited 
the amplitude, and sometimes the frequency, of the spontaneous, rhythmic contractions, and 
relaxed the uterine muscle preparations in a concentration-related manner. Figure 2 shows a 
typical trace obtained with a pregnant guinea-pig isolated uterine horn, while Fig. 3 summarizes 
results obtained with rat and guinea-pig uterine horns. In all cases, moderate to high 
concentrations of APE (200-400) always caused profound relaxations of uterine horns taken 
from pregnant rats and guinea-pigs in a concentration-dependent fashion (Fig. 4). 
Effects of APE on uterine horns isolated from oestrogen-dominated, non-pregnant rats and guinea-pigs 
Uterine horns taken from stilboesterol-primed, and oestrogen-dominated, non-gregnant 
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Fig. 2. Relaxant effect of APE ©00 mg/ml) on a pregnant guinea-pig isolated uterine horn, 
APE was added to the bath-fluid at the left-hand side solid, upward-pointing arrow, and 
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Fig. 3, Comparative relaxant effects of graded concentrations of APE on pregnant rat (O—D) 
and pregnant guinea-pig (•—•) isolated uterine horns. Each point represents the 
mean of 6-8 observations, while the vertical bars denote standard errors of the means 
(SEM). *, f<0.05; **, P<0.01; ***, P<0.001. 
(normal) rats and guinea-pigs were always quiescent and devoid of spontaneous, rhythmic 
contractions (unlike uterine horns isolated from pregnant rats and guinea-pigs). Relatively low 
to high concentrations of APE (25-400 mg/ml) always relaxed the basal tones of the uterine 
horn muscle preparations in a concentration-dependent manner. The same low to high 
concentrations of APE (25-400 mg/ml) always inhibited ACh~, oxytocin-, bradykinin- or 
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Fig. 4. Relaxant effects of graded concentrations of APE on pregnant rat isolated uterine 
horns. APE 1 and 2 represent 300 mg/ml and 400 rag/ml of APE. respectively, added 
to the bath-fluid at the left-hand side solid dots (#); and washed out 4-5 times at the 
adjacent right-hand side open, downward-pointing arrows. 
potassium chloride-induced contractions of the oestrogen-dominated uterine horns in a 
concentration-related manner (data not shown). 
Discussion 
The LDso value for intraperitoneally-administered APE was found to be 1,785 ± 116 rng/kg, 
while the LDso value for orally-administered APE was 3.72 ± 0.45 g/kg. The gut wall and hepatic 
'first pass' metabolic and elimination processes, coupled with the slow and variable degree of 
absorption following oral administration of APE would result in low blood (systemic) levels of the 
extract that would be non-toxic and non-lethal to the animals. On the contrary, the relatively rapid 
absorption following intraperitoneal administration of APE would result in high systemic levels of 
the extract, leading to toxic effects in the animals. The differences in blood concentrations of the 
extract following oral and intraperitoneal routes of administration would, therefore, seem to 
account for the differences obtained for the LDso values of APE in the acute toxicity studies. 
The effects of some cations, anions and certain drugs on spontaneous activities of uterine 
smooth muscle strips taken from non-pregnant and pregnant mammals have been investigated 
by a number of workers (Kuriyama and Suzuki, 1976; Osa and Kawarabayashi, 1977; Kuriyama 
et al, 1998). Pharmacologically, relaxations of uterine smooth muscle strips taken from non-
pregnant and pregnant mammals are believed to be mediated via /^adrenoceptor stimulation. 
However, the results of the present study indicate that APE possesses uterolytic activity in the 
mammalian experimental animals used. To the best of our knowledge, this is the first report on 
uterine activity of H. hemerocallidea corm in biomedical literature. The findings of our study are 
in agreement with the observations reported by Kuriyama and Suzuki (1976), Osa and 
Kawarabayashi (1977) and Kuriyama et al (1998). 
However, previous studies in our laboratories and elsewhere have reported antidiabetic, 
hypoglycaemic, anti-inflammatory and analgesic (Ojewole, 2002; 2006; Mahomed and Ojewole, 
2003); antibacterial, anti-inflammatory and antioxidant (Steenkamp et al, 2006); anti-cancer 
(Albrecht et al, 1995); and renal (Musabayane et al., 2005) effects of APE in various 
experimental animal paradigms. The above pharmacotherapeutic effects of'African Potato' have 
been ascribed to the sterols, stanols, steroltns and norlignan glycoside, hypoxoside, present in 
the corm (Drewes et al, 1984; Albrecht et al, 1995; Bouic et al, 1996; Nair et al, 2007). The best-
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known and fully-established chemical constituents of the plant's corm are presented in Fig. 1. 
APE (25-400 mg/kg p.o.) dose-dependently and significantly (P<0.05-0.01) inhibited the 
amplitude (and in some cases, the frequency) of the spontaneous, rhythmic contractions of, and 
relaxed, pregnant rat and guinea-pig uterine horn preparations in a concentration-dependent 
manner. The same low to high concentrations of APE (25-400 mg/ml) also inhibited ACh-, 
oxytocin-, bradykinin-, or potassium chloride-induced contractions of oestrogen-dominated, non-
pregnant rat and guinea-pig uterine horn preparations in a concentration-related manner (data not 
shown), suggesting that APE-induced uterine horn relaxations are unlikely to be mediated 
through /^-adrenoceptor stimulation. Recent studies in our laboratories (Nyinawumuntu and 
Ojewole, 2008 - unpublished observation) have shown that APE provoked concentration-related 
inhibitions of the spontaneous, rhythmic, peristaltic contractions of the rabbit isolated duodenum, 
and relaxed the muscle. Moreover, it has been observed that APE relaxed guinea-pig isolated 
ileum in a concentration-related manner, and antagonized ACh-, histamine-, serotonin-, and 
potassium chloride (K*)-induced contractions of the guinea-pig ileum in a concentration-
dependent manner (Nyinawumuntu and Ojewole, 2008 - unpublished observation). The above 
observations are in consonance with the findings of the present study which suggest that APE 
possesses antimotility and non-specific spasmolytic effects. However, the spasmolytic effects of 
APE on spasmogen-induced contractions of uterine horn muscle strips taken from stilboesterol-
primed, oestrogen-dominated, non-pregnant rats and guinea-pigs, like the spasmolytic effects of 
the plant's extract on rabbit and guinea-pig intestinal smooth muscles, would appear to be 
mediated through a non-specific spasmolytic mechanism. The sterols, stanols and sterolins 
present in H. hemerocallidea corm, especially rooperol and /^sitosterol (see Fig. 1), are speculated 
to account for the uterolytic and spasmolytic activities of APE. Further studies are, however, 
required to clarify this speculation. In conclusion, experimental evidence obtained in the present 
laboratory animal study indicates that Hypoxis hemerocallidea corm aqueous extract possesses 
uterolytic activity. This finding lends pharmacological support to the anecdotal, efhnomedical 
uses of 'African Potato' as a natural supplementary antenatal remedy for the management and/or 
control of threatening or premature abortion in some rural communities of South Africa. 
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